These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2112976)

  • 1. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer.
    Jacquillat C; Weil M; Baillet F; Borel C; Auclerc G; de Maublanc MA; Housset M; Forget G; Thill L; Soubrane C
    Cancer; 1990 Jul; 66(1):119-29. PubMed ID: 2112976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor regression as a prognostic factor in breast cancer].
    Jacquillat C; Weil M; Borel C; Auclerc G; de Maublanc MA; Housset M; Baillet F; Khayat D
    Bull Cancer; 1991; 78(5):435-43. PubMed ID: 1878605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB).
    Jacquillat C; Baillet F; Weil M; Auclerc G; Housset M; Auclerc M; Sellami M; Jindani A; Thill L; Soubrane C
    Cancer; 1988 May; 61(10):1977-82. PubMed ID: 3129176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in the conservative management of breast cancer: a study of 252 patients.
    Jacquillat C; Weil M; Auclerc G; Auclerc MF; Khayat D; Baillet F
    Recent Results Cancer Res; 1989; 115():36-42. PubMed ID: 2516351
    [No Abstract]   [Full Text] [Related]  

  • 5. [Breast cancer: chemotherapy preceding locoregional treatment with extension of the indications for conservative treatment].
    Jacquillat C; Baillet F; Auclerc G; Blondon J; Auclerc MF; Facchini T; Lefranc JP; Weil M
    Bull Cancer; 1984; 71(4):354-60. PubMed ID: 6437462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary chemotherapy in the treatment of breast cancer].
    Auclerc G; Borel C; Khayat D; Soubrane C; Weil M
    Ann Chir Plast Esthet; 1992 Dec; 37(6):663-9. PubMed ID: 1340170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer.
    Semiglazov VF; Topuzov EE; Bavli JL; Moiseyenko VM; Ivanova OA; Seleznev IK; Orlov AA; Barash NY; Golubeva OM; Chepic OF
    Ann Oncol; 1994 Sep; 5(7):591-5. PubMed ID: 7993833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
    Lichtman SM; Budman D; Bosworth H; Allen S; Schulman P; Weiselberg L; Weiss R; Lehrman D; Vinciguerra V
    Am J Clin Oncol; 1991 Aug; 14(4):317-21. PubMed ID: 1907428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study.
    Perloff M; Norton L; Korzun AH; Wood WC; Carey RW; Gottlieb A; Aust JC; Bank A; Silver RT; Saleh F; Canellos GP; Perry MC; Weiss RB; Holland JF
    J Clin Oncol; 1996 May; 14(5):1589-98. PubMed ID: 8622076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
    Hortobagyi GN; Ames FC; Buzdar AU; Kau SW; McNeese MD; Paulus D; Hug V; Holmes FA; Romsdahl MM; Fraschini G
    Cancer; 1988 Dec; 62(12):2507-16. PubMed ID: 3056604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
    Swain SM; Sorace RA; Bagley CS; Danforth DN; Bader J; Wesley MN; Steinberg SM; Lippman ME
    Cancer Res; 1987 Jul; 47(14):3889-94. PubMed ID: 3036348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
    Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
    J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actual 5-year survival of patients with stage IIIB breast carcinoma: phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acid.
    Madajewicz S; Matei D; Hentschel P; Kudelka A; Abel W; Fiore JJ; DaCosta NA; Pendyala L
    Cancer Invest; 1999; 17(7):463-7. PubMed ID: 10518189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
    J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for locally advanced breast cancer--experience in an Asian tertiary hospital.
    Chong HY; Taib NA; Rampal S; Saad M; Bustam AZ; Yip CH
    Asian Pac J Cancer Prev; 2010; 11(4):913-7. PubMed ID: 21133600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
    Fisher B; Brown AM; Dimitrov NV; Poisson R; Redmond C; Margolese RG; Bowman D; Wolmark N; Wickerham DL; Kardinal CG
    J Clin Oncol; 1990 Sep; 8(9):1483-96. PubMed ID: 2202791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adjuvant chemotherapy in male breast cancer.
    Patel HZ; Buzdar AU; Hortobagyi GN
    Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.